# Investigation of the Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) and Vestibular Rehabilitation in Patients with Unilateral Vestibular Hypofunction

**Authors:** Tuğba Türk Kalkan, Devrim Tarakçi, Gamze Kiliç, Cengiz Çelikyurt

PMC · DOI: 10.3390/medicina61050872 · Medicina · 2025-05-09

## TL;DR

This study found that adding transcutaneous auricular vagus nerve stimulation to vestibular rehabilitation improves balance and reduces dizziness in patients with unilateral vestibular hypofunction.

## Contribution

The novel contribution is demonstrating that taVNS enhances vestibular rehabilitation outcomes for UVH patients.

## Key findings

- Patients receiving taVNS and vestibular rehabilitation showed greater improvement in balance and reduced dizziness.
- taVNS also significantly reduced fatigue, kinesiophobia, anxiety, and depression.
- No significant difference was found in visual acuity or quality of life between groups.

## Abstract

Background and Objectives: Vagus nerve stimulation (VNS) is a frequently used neuromodulation method in recent years. While the mechanism of improvement in diseases such as epilepsy, dementia, and depression is being studied, its potential effect on vestibular dysfunction is also being investigated. The aim of our study was to investigate the effect of transcutaneous auricular VNS (taVNS) on the vestibular symptoms of unilateral vestibular hypofunction (UVH). Materials and Methods: Forty patients diagnosed with UVH were randomly divided into two groups. Group 1 received vestibular rehabilitation. Group 2 received taVNS and vestibular rehabilitation. Both groups received treatment one day a week for eight weeks. Before and after the treatment, balance of the participants was assessed with modified-CTSIB (m-CTSIB), limit of stability (LOS), Tandem and One-Leg Stance (OLS) tests; visual acuity was assessed with dynamic visual acuity (DVA), dizziness severity, and fatigue severity with a visual analog scale (VAS); kinesiophobia was assessed with the Tampa Scale for Kinesiophobia (TSK); depression and anxiety was assessed with the Hospital Anxiety and Depression Scale (HADS); and quality of life was assessed with the Dizziness Handicap Inventory (DHI). Results: At the end of eight weeks, patients in Group 2 showed significantly greater improvement in balance, dizziness, fatigue, kinesiophobia, anxiety, and depression. There was no significant difference in visual acuity and quality of life between the groups. Conclusions: The positive effects of taVNS on vestibular symptoms have been observed. As a new approach, taVNS can be included in the treatment of patients with UVH in addition to vestibular rehabilitation.

## Linked entities

- **Diseases:** epilepsy (MONDO:0005027), dementia (MONDO:0001627), depression (MONDO:0002050)

## Full-text entities

- **Diseases:** dementia (MESH:D003704), UVH (MESH:D000309), fatigue (MESH:D005221), epilepsy (MESH:D004827), vestibular dysfunction (MESH:D015837), Anxiety (MESH:D001007), Depression (MESH:D003866), Dizziness (MESH:D004244), Kinesiophobia (MESH:D000092442)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12113213/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12113213/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12113213/full.md

---
Source: https://tomesphere.com/paper/PMC12113213